260 related articles for article (PubMed ID: 19088040)
1. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.
Abou-Ghazal M; Yang DS; Qiao W; Reina-Ortiz C; Wei J; Kong LY; Fuller GN; Hiraoka N; Priebe W; Sawaya R; Heimberger AB
Clin Cancer Res; 2008 Dec; 14(24):8228-35. PubMed ID: 19088040
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
[TBL] [Abstract][Full Text] [Related]
3. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
[TBL] [Abstract][Full Text] [Related]
4. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target.
Barnett JA; Urbauer DL; Murray GI; Fuller GN; Heimberger AB
Clin Cancer Res; 2007 Jun; 13(12):3559-67. PubMed ID: 17575219
[TBL] [Abstract][Full Text] [Related]
6. The association of Crk-like adapter protein with poor prognosis in glioma patients.
Yao C; Lv S; Han M; Zhang J; Zhang Y; Zhang L; Yi R; Zhuang D; Wu J
Tumour Biol; 2014 Jun; 35(6):5695-700. PubMed ID: 24563280
[TBL] [Abstract][Full Text] [Related]
7. [Expression of cyclin D1 in brain gliomas and its significance].
Tan PG; Xing Z; Li ZQ
Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between TGF- β1 expression and Treg cell infiltration in glioma].
Zhang GH; Jiang XB; Zhang XH; Sai K; Yang QY; Chen ZP; Mou YG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):680-2. PubMed ID: 21882476
[TBL] [Abstract][Full Text] [Related]
9. Ki-67: a prognostic factor for low-grade glioma?
Fisher BJ; Naumova E; Leighton CC; Naumov GN; Kerklviet N; Fortin D; Macdonald DR; Cairncross JG; Bauman GS; Stitt L
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):996-1001. PubMed ID: 11958894
[TBL] [Abstract][Full Text] [Related]
10. Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes.
Pi Castro D; José-López R; Fernández Flores F; Rabanal Prados RM; Mandara MT; Arús C; Pumarola Batlle M
J Neuropathol Exp Neurol; 2020 Feb; 79(2):184-193. PubMed ID: 31846038
[TBL] [Abstract][Full Text] [Related]
11. PinX1 is up-regulated and associated with poor patients' survival in gliomas.
Bai J; Chen YS; Mei PJ; Liu QH; Du Y; Zheng JN
Int J Clin Exp Pathol; 2015; 8(6):6952-9. PubMed ID: 26261583
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic expression of BAP1 as an independent prognostic biomarker for patients with gliomas.
Zhang XK; Xi SY; Sai K; Chen HD; Zhong ZH; Wu QL; Zeng J
Int J Clin Exp Pathol; 2015; 8(5):5035-43. PubMed ID: 26191197
[TBL] [Abstract][Full Text] [Related]
13. PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification.
Muracciole X; Romain S; Dufour H; Palmari J; Chinot O; Ouafik L; Grisoli F; Branger DF; Martin PM
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):592-8. PubMed ID: 11849778
[TBL] [Abstract][Full Text] [Related]
14. Clonal analysis of gliomas.
Kattar MM; Kupsky WJ; Shimoyama RK; Vo TD; Olson MW; Bargar GR; Sarkar FH
Hum Pathol; 1997 Oct; 28(10):1166-79. PubMed ID: 9343324
[TBL] [Abstract][Full Text] [Related]
15. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
16. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
[TBL] [Abstract][Full Text] [Related]
17. Using gene expression profiling to identify a prognostic molecular spectrum in gliomas.
Shirahata M; Oba S; Iwao-Koizumi K; Saito S; Ueno N; Oda M; Hashimoto N; Ishii S; Takahashi JA; Kato K
Cancer Sci; 2009 Jan; 100(1):165-72. PubMed ID: 19038000
[TBL] [Abstract][Full Text] [Related]
18. Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours.
Häyry V; Tynninen O; Haapasalo HK; Wölfer J; Paulus W; Hasselblatt M; Sariola H; Paetau A; Sarna S; Niemelä M; Wartiovaara K; Nupponen NN
Neuropathol Appl Neurobiol; 2008 Oct; 34(5):555-63. PubMed ID: 18346113
[TBL] [Abstract][Full Text] [Related]
19. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
Pollack IF; Claassen D; al-Shboul Q; Janosky JE; Deutsch M
J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
[TBL] [Abstract][Full Text] [Related]
20. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.
Lo HW; Cao X; Zhu H; Ali-Osman F
Clin Cancer Res; 2008 Oct; 14(19):6042-54. PubMed ID: 18829483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]